Last reviewed · How we verify
EverX Posterior
At a glance
| Generic name | EverX Posterior |
|---|---|
| Also known as | Fiber reinforced bulk fill dentine substitute |
| Sponsor | Cairo University |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Clinical Evaluation of Short Fiber-Reinforced Composite Restorations With and Without Preheating Approach (NA)
- Clinical Performance of Various Bilayer Biomimetic Resin Composite Strategies (NA)
- Evaluation of the Clinical Success of Direct Restorations of Endodontically Treated Posterior Teeth in the Presence of Parafunction: A Pilot Study (NA)
- Digital, Conventional, And Biomimetic Approaches for Restoring Endodontically Treated Teeth (NA)
- Clinical Performance of Fiber Reinforced FRC Base and Bonded CAD/CAM Resin Composite Endocrowns (NA)
- Clinical Evaluation of Fiber Reinforced Resin Composite Base Versus Incremental Packing of Nanohybrid Resin Composite (EARLY_PHASE1)
- Clinical Performance of Short Fiber Reinforced Flowable Resin Composite Restorations 2y RCT (NA)
- A 24-month Clinical Evaluation of Different Bulk-fill Restorative Resins in Class II Restorations (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- EverX Posterior CI brief — competitive landscape report
- EverX Posterior updates RSS · CI watch RSS
- Cairo University portfolio CI